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Summary
The conversion to mucoid phenotype in Pseudomo-
nas aeruginosa during chronic infections in cystic
fibrosis (CF) is due to mutations in the algU
mucABCD gene cluster. This cluster encodes an
extreme stress response system conserved in Gram-
negative bacteria. The system includes an ECF sigma
factor, AlgU (sE), an inner membrane protein, MucA,
which inhibits AlgU activity, and MucB, a periplasmic
protein that negatively controls AlgU. In this work, we
investigated whether and how these factor interact to
transduce signals between different cellular compart-
ments. The mutation mucADG440, which renders a
large fraction of P. aeruginosa CF isolates mucoid,
did not abrogate AlgU±MucA interactions, although it
eliminated MucA±MucB interactions in the yeast two-
hybrid system. The mucADG440 truncation of the
periplasmic C-terminal tail of MucA destabilized the
molecule resulting in low or undetectable steady-
state levels in P. aeruginosa. Somewhat reduced
levels of MucA were also seen in cells with inacti-
vated mucB or with the mucACF53 allele carrying
the missense P184S mutation, which mildly affected
interactions with MucB. The events downstream from
MucA destabilization were also investigated. AlgU
was found to associate with inner membranes in
mucA1 cells. In mutants destabilizing MucA, a limited
redistribution of AlgU from the membrane to the
cytosol was observed. The redistribution was spon-
taneous in mucADG440 cells, while in mucB and
mucACF53 mutants it required additional signals.
Despite a large reduction in MucA levels in
mucADG440 cells, only a small fraction of AlgU was
redistributed to the cytosol and a significant portion
of this s factor remained membrane bound and
behaved as a peripheral inner membrane protein.
The fraction of AlgU that depended on MucA for
association with the membrane also brought RNA
polymerase into this compartment. These results
are consistent with a model in which MucB±MucA±
AlgU±RNA polymerase interactions at the membrane
allow transduction of potentially lethal stress signals
with both rapid reaction times of the preassembled
complexes and efficient resupply at the membrane
from the prebound components.
Introduction
The conversion to mucoid phenotype in Pseudomonas
aeruginosa, associated with the establishment of chronic
respiratory infections in cystic fibrosis (CF) (Deretic et al.,
1995; Govan and Deretic, 1996), is caused by mutations
within the algU mucABCD gene cluster (Martin et al.,
1993a,b,c; Boucher et al., 1997a,b), which encodes the
sigma factor AlgU (Martin et al., 1993), also known as AlgT
(DeVries and Ohman, 1994), and four other regulatory
proteins (Martin et al., 1993a,b,c; Boucher et al., 1996;
1997a). AlgU is required for transcriptional initiation of
alginate biosynthetic genes which when upregulated cause
the mucoid phenotype (Martin et al., 1993a,b,c; DeVries
and Ohman, 1994; Martin et al., 1994). MucA is believed to
associate with AlgU and inhibit its activity (Schurr et al.,
1996; Xie et al., 1996). Consequently, mutations in mucA
are associated with increased expression of AlgU-
dependent genes (Martin et al., 1993c).
The algU mucABCD gene cluster is conserved, with
some variations, in Gram-negative bacteria (Deretic et al.,
1995; Missiakas and Raina, 1998). Besides controlling
alginate production, AlgU is the P. aeruginosa equivalent
of the extreme heat shock sigma factor sE of Escherichia
coli (Yu et al., 1995). Both AlgU (Schurr et al., 1995a;
Schurr and Deretic, 1997) and sE (Erickson and Gross,
1989; Raina et al., 1995; RouvieÂre et al., 1995) control
extreme stress response in these organisms. MucA and
its E. coli homologue RseA have recently been shown to
be located in the inner membrane via a single transmem-
brane domain with its amino terminus in the cytoplasm
and its carboxy terminus in the periplasm (De Las Penas
et al., 1997; Mathee et al., 1997; Missiakas et al., 1997).
MucB (Schurr et al., 1996; Mathee et al., 1997) and its
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E. coli equivalent homologue RseB (De Las Penas et al.,
1997; Missiakas et al., 1997) are located in the periplasm.
Inactivation of mucB is conducive to alginate overproduc-
tion under certain growth conditions (Martin et al., 1993b).
Although the precise mechanism of MucB action is not
known, its periplasmic location is essential for its function
(Schurr et al., 1996). MucC and its homologues contain
two putative transmembrane domains and are thought to
be located in the inner membrane (Boucher et al., 1997a).
MucC displays only a mild negative effect on AlgU
detectable exclusively in synergy with MucA or MucB
(Boucher et al., 1997a). MucD (Boucher et al., 1996) is
homologous to the periplasmic serine protease HtrA or
DegP (Lipinska et al., 1988; Strauch and Beckwith, 1988)
and is believed to act as an extreme stress response
effector via the removal of denatured or damaged
proteins.
Because the algU mucABCD system is highly con-
served in Gram-negative organisms, analyses of the
regulation of AlgU by MucA and MucB may serve as a
model for understanding recognition and signal transduc-
tion in response to extreme stress conditions. A recent
study of a collection of mucoid P. aeruginosa isolates from
CF patients, revealed that over 80% of the alginate-
overproducing clinical strains have mutations in mucA
(Boucher et al., 1997b). This pool of mutants provides a
resource to help dissect the regulation of AlgU by MucA.
The most frequent lesion type (Boucher et al., 1997b) in
mucoid CF isolates is represented by the mucADG440
allele (Fig. 1), which is a frameshift mutation located
within the last third of the gene encoding the periplasmic
domain of MucA. The importance of the periplasmic
domain of MucA is underscored by the findings that loss
of MucB, which acts in the periplasm (Schurr et al., 1996),
also leads to the mucoid phenotype (Martin et al., 1993b).
It is not known how periplasmic MucB and periplasmic
domains of MucA affect AlgU in the cytoplasm. Moreover,
the activity of MucA remains to be explained in the context
of its membrane localization. In one model, AlgU could be
sequestered by MucA in the membrane, but the mem-
brane association of AlgU has not been investigated. In
this work, we have initiated studies of how MucA and
MucB affect AlgU localization. Our results suggest that
mutations in the carboxy terminus of MucA typically found
in clinical isolates affect both the stability of this protein
and its interactions with MucB. In addition, we present the
unexpected phenomenon that AlgU associates with the
inner membrane even in strains containing undetectable
amounts of MucA, albeit a subpopulation of AlgU
molecules redistributes from the membrane to the cytosol
in the absence of MucA. These observations and
additional findings are consistent with a model in which
MucA affects translocation from the membrane of a
fraction of AlgU associated with RNA polymerase. This
system, which is designed to provide response to stress
conditions, is deregulated due to mucA mutations in
mucoid P. aeruginosa.
Results and discussion
Interactions of mutant forms of MucA with AlgU and MucB
Most mucoid clinical or laboratory isolates of P. aerugi-
nosa have mutations causing truncation of the carboxy
terminal domain of MucA (Boucher et al., 1997b). One
possibility is that these mutations affect the ability of MucA
to bind AlgU. Alternatively, because these mutations
affect the putative periplasmic domain of MucA, interac-
tions between MucA and the periplasmic regulatory
protein MucB may be disturbed. We examined the ability
of representative forms of MucA to interact with AlgU and
MucB. We focused our studies on three different mucA
alleles found in clinical isolates (Fig. 1): (i) mucADG440,
the most common frameshift mutation in CF isolates,
which deletes the last 50 amino acids of the protein
(Martin et al., 1993c; Boucher et al., 1997b); (ii) mucACF53,
an allele carrying the missense mutation Pro184!Ser184;
and (iii) mucACF16, an allele that has an in frame deletion
of 42 bp that causes the loss of amino acid residues 114±
127 within the periplasmic domain of the MucA protein.
The rationale for choosing these mucA forms is based on
Fig. 1. Schematic representation of mutant MucA forms. Filled
rectangle, the putative transmembrane domain (residues 85±104) of
MucA. Semi-circle within the periplasmic domain of MucA, putative
region that destabilizes interactions with MucB. Oval (AlgU) and
rectangle (MucB) are depicted as interacting with the cytoplasmic N-
terminal domain and the C-terminal periplasmic domain of MucA
respectively. The mutation mucADG440 is common among CF
strains. This frameshift mutation causes the loss of the C-terminal 50-
amino-acid residues of MucA with termination four triplets
downstream resulting in the addition of three amino acids (as
indicated by the raised tail). MucACF16 has an in-frame deletion that
results in a loss of the residues 114±127. MucACF53 has a missense
Pro184!Ser184 mutation (P184S). MucA±FLAG has the eight-amino-
acid FLAG epitope added to the MucA C-terminus.
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the mucADG440 allele being the most common type
of mutation found in CF isolates and mucACF53 and
mucACF16 representing the rare mutations or polymorph-
isms that do not cause premature termination of mucA
and thus could be potentially informative about the
structure±function of MucA.
We first tested the effects of the mucA alleles on
alginate production/mucoid status of P. aeruginosa by
gene replacements in the standard genetic strain PAO1:
mucADG440 and mucACF53 alleles rendered cells
mucoid (producing 383.2 ^ 25.3 mg and 99.8 ^ 9.4 mg
of uronic acid per mg wet weight of cells, respectively,
compared with PAO1 levels of 1.0 ^ 0.1 mg of uronic acid
per mg wet weight of cells) when grown on the medium
routinely used to assess mucoid status of P. aeruginosa
(PIA; see Experimental procedures). The levels of
alginate production in mucACF53 cells were somewhat
less than in mucADG440 cells, consistent with the
possibility that the missense mutation P184S in
mucACF53 was less severe than the mucADG440
truncation. The replacement of mucA1 with mucACF16
on the chromosome of PAO1 did not increase alginate
production and the strain remained non-mucoid (0.6 ^
0.1 mg of uronic acid per mg wet weight of cells). Thus,
the truncation mutation mucADG440 and the missense
mutation P184S are responsible for the mucoid pheno-
type in the respective CF isolates. In contrast, mucACF16
is most likely a naturally occurring polymorphism.
To investigate interactions with AlgU and MucB in the
yeast two hybrid system, the mucA alleles were fused to
the GAL4 activation domain (AD) in plasmid pACT2, while
the algU and mucB genes were fused to the GAL4 DNA
binding domain (BD) of plasmid pAS2-1. Interactions
between the chimeric proteins were examined by moni-
toring the expression of both the GAL1±lacZ and
GAL1UAS±HIS3 reporter genes in diploid yeast cells
generated from the mating of the Saccharomyces
cerevisiae strains Y187 and Y190 carrying either the BD
plasmids or the AD plasmids respectively. Although the
obtained values for b-galactosidase were relatively low,
this assay permitted quantitative comparisons (Table 1).
The wild-type MucA indeed interacted with MucB
(Table 1). Consistent with the model in which the
periplasmic domain of MucA interacts with the periplasmic
protein MucB, mutations within the carboxy terminus of
mucA affected this interaction. No interactions between
MucADG440 and MucB were detected, although
MucADG440 interacted with AlgU. The missense muta-
tion P184S (mucACF53) within the C-terminus of MucA
showed slightly reduced interactions with MucB
(P  0.04, t-test). Similarly, addition of the FLAG epitope
to the C-terminal end of MucA (Fig. 1) reduced interac-
tions with MucB (Table 1). The mucACF16 allele (deletion
of amino acids 114±127) displayed increased interactions
with MucB. Surprisingly, all tested MucA mutant forms
showed equally strong interactions with AlgU compared
with the wild-type MucA in the two-hybrid system (Table 1).
These results suggest that alterations within the C-terminus
of MucA influence the capacity of MucA to interact with
MucB while not interfering with its affinity for AlgU.
Truncation of MucA C-terminal domain affects its stability
in P. aeruginosa
The two-hybrid analyses and the previous observations
that the loss of MucB causes mucoidy (Martin et al., 1993b)
suggest that the interaction of MucB with MucA may play
a role in enabling MucA to inhibit AlgU. We next
considered whether MucB±MucA interactions either
helped stabilize the MucA protein (e.g. by preventing its
degradation) or affected functions of its cytosolic domain
by exerting effects on AlgU via conformational changes.
We first examined MucA levels in the three prototypical
mucA mutants described in the previous section using
antibodies raised against a portion of the amino terminal
cytoplasmic domain of full-size MucA (residues 38±56;
see Experimental procedures). Cells with the mucA
truncation DG440 showed absence of a full-size MucA
(Fig. 2A) and its putative truncation product of < 16 kDa
(Fig. 2B) was at the levels corresponding to 15% relative
to the mucA1 cells as judged by Western blot signal
intensity (Fig. 3). The P184S missense mutation
(mucACF53) showed somewhat reduced levels of MucA
(74 ^ 7% of wild-type levels; P  0.05, ANOVA) (Fig. 2A).
The mucACF16 in frame 14 amino acid deletion, which
does not cause mucoidy, showed increased levels of MucA
(CF16 variant with Mr of 19 kDa) relative PAO1. Because
mutations within the carboxy terminus of MucA affected
interactions with MucB, we also examined the levels of
MucA in P. aeruginosa with inactivated mucB. We observed
a 57 ^ 6% (P  0.0001, ANOVA) reduction in MucA levels
(Fig. 2A, lane B± and Fig. 3). A small amount of potential
degradation intermediates could be sporadically detected
in some samples from mucACF53 and mucB mutant
strains. These results suggest that the loss or reduction
of interactions between MucA and MucB leads to a
destabilization of MucA diminishing its steady-state levels.
In the case of the truncation of the MucA C-terminal
domain, the destabilization of this protein appeared to be
more complete (Fig. 3). The absence of a full-size MucA
in mucADG440 cells coincided with either the presence of
small amounts (15% relative to the wild type levels) of a
16 kDa band, which corresponded to the expected size of
the truncated version of MucA. Figure 2B illustrates the
highest levels of the 16 kDa band reacting with anti-MucA
antibodies that could be detected. In the majority of
extracts, the band could not be distinguished from
background bands or from a similar band (Fig. 2B, lane
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A1) present in mucA1 cells. The low levels or absence of
MucA in mucADG440 cells are in keeping with the
strongest phenotypic effects of this mucA allele on
alginate production, as described in previous sections.
To determine whether other representative mucA
mutations found in CF isolates affect MucA stability, we
also examined the levels of MucA in a panel of CF isolates
with different truncation mutations (Fig. 2B). The pre-
dicted sizes of the truncated MucA versions in these
strains varied from 15.5 to 17.0 kDa. Some cross-
reactivity with the MucA antibody was observed in the
region of the blot containing the low Mr polypeptides, but
the bands did not correspond to the expected truncated
version of MucA. The most consistently observed cross-
reactive band of 16 kDa was also seen in mucA1 cells
and its intensity was lower in mucA truncation mutants
compared with the full-size MucA in wild-type cells. These
results are consistent with the possibility that the majority
of mutations in mucA causing mucoidy in CF isolates
destabilize MucA.
Mutant mucA alleles are able to inhibit AlgU when
overexpressed.
Our studies suggest that mutations in mucA result in
reduced levels of MucA (Figs 2 and 3). When over-
expressed, the majority of the mucA alleles tested were
able to reduce alginate production when overexpressed in
the strain PAO578I (mucADG440) (Table 2), suggesting
that all mutant forms retained some ability to inhibit AlgU.
However, the mucADG440 allele and the C-terminal
tagged mucA-FLAG form, when overexpressed, were
able to inhibit alginate production only partially (Table 2).
In contrast, the mucACF53 allele, was able to inhibit
AlgU as efficiently as a mucA1 clone. The mucACF16
allele inhibited AlgU better than the wild-type mucA, as
evidenced by the reduced alginate production and
morphological changes (less pronounced mucoidy),
even in the absence of the inducer IPTG. Immunoblots
of extracts from these cells detected high levels of the
MucA mutant forms except the C-terminal tagged MucA-
FLAG and the truncated MucADG440 (data not shown).
These results indicate that mutant MucA forms retain the
ability to inhibit AlgU activity when present in sufficient
amounts. The complementation of chromosomal mucA
mutations with plasmid borne mucA1 was also an
illustration of the direct effects of mucA inactivation rather
than polar effects on the downstream genes.
Fig. 2. MucA in wild type and mucoid cells.
A. Immunoblot analysis of total protein extracts from isogenic mucA
variants constructed in the PAO1 background. The strains were
grown in LB media and extracts prepared as described in
Experimental procedures. Equal protein amounts were separated by
SDS±PAGE, electroblotted to Immobilon P membranes, and probed
with affinity purified antibody to the N-terminal domain of MucA.
Predicted Mr of MucA and MucACF16 are indicated. A
±, PAO6852
(algU::Tcr::mucA); A1, PAO1 (mucA1); DG, PAO578I
(mucADG440); 16, PAO6901 (mucACF16); 53, PAO6902
(mucACF53); and B± PAO6857 (mucB::Tcr).
B. Analysis of MucA in a panel of clinical isolates and laboratory
strains with mucA truncation mutations. DG440 I and II, PAO578I
mucADG440 and PAO578II mucADG440 sup-2 respectively; CF
isolates (indicated by numbers only) contained assorted frameshift or
nonsense mutations (CF9, CF20, CF33 and CF42) or were identical
to mucADG440 (CF14 and CF23) (Boucher et al., 1997). A± and A1
as in panel A. The wild type and predicted Mr of truncated
polypeptides are indicated above each lane. Bars, Mr standards
(kDa).
Table 1. Effect of representative alterations in mucA on interactions




AD fusiona BD vector AlgU MucB
AD-MucA ,0.01d 2.47 ^ 0.34 3.69 ^ 1.11
AD-MucADG440 ND 4.03 ^ 1.65 ,0.01
AD-MucACF53 ND 2.45 ^ 0.27 1.99 ^ 0.22
AD-MucACF16 ND 3.52 ^ 0.10 13.83 ^ 2.27
AD-MucA±FLAG ND 1.72 ^ 0.06 1.33 ^ 0.34
AD vector ND 0.05 ^ 0.01 ,0.01
a. MucA variants were fused to the Gal4 activation domain (AD) of
plasmid pAS2-1. A summary of the characteristics of the MucA
variants is given in Fig. 1.
b. BD, Gal4 binding domain fusions with AlgU, MucB. BD-vector,
control with no fusion.
c. Interactions were assessed by measuring the expression of the
GAL1±lacZ reporter gene in Y187/Y190 diploid yeast cells carrying
the indicated pairs of plasmids. b-Galactosidase activity in at least
three independent cultures grown in SDC -Leu/Trp/His media was
determined as described in Experimental procedures. The mean
values ^ SE are reported in Miller units normalized for optical density
of the culture at 600 nM. A competitive inhibitor of imidazole glycerol-
phosphate dehydrogenase (His3), 3-amino-triazole, was added to
cultures showing positive interaction (b-galactosidase activity . 1.0)
to ensure greater retention of the plasmids and more consistent b-
galactosidase activity. ND, activity not determined; these samples
showed b-galactosidase staining in colony filter assays comparable
to samples with activities below the limit of detection.
d. Below detection limit (0.01 U/OD600).
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Localization of AlgU in wild type and mucA mutant cells
Based on the two-hybrid analysis, MucA, which spans the
inner membrane, most likely forms a complex with AlgU
via its N-terminal cytoplasmic domain and with MucB via
its C-terminal periplasmic domain. In one model of how
MucA works, its complex with AlgU (possibly stabilized
by MucA±MucB interaction) may sequester AlgU to the
membrane, thereby limiting its availability to initiate
transcription of subordinate promoters. In this model, a
redistribution of AlgU from membranes to the cytosol
could serve as a readout of its reduced association with
MucA. We tested the localization of AlgU in wild type and
mucA mutant cells. For these experiments, cellular
membranes were separated from soluble cytoplasmic
proteins by high-speed centrifugation of total cellular
extracts prepared as described in Experimental proce-
dures. The levels of AlgU in membrane (M) and cytosolic
(C) fractions were determined by immunoblot analysis
using monoclonal antibodies specific for AlgU (Fig. 4).
The relative levels of AlgU in each sample were quantified
by densitometry (Fig. 4, lower panel).
In the wild-type PAO1 cells, AlgU was found predomi-
nantly in the membrane fraction (67 ^ 1%). Surprisingly,
examination of the localization of AlgU in mucADG440
cells revealed that a large proportion of AlgU was still
associated with the membrane (54 ^ 4%) (Fig. 4). The
presence of AlgU in the membrane fraction did not result
from its sedimentation as part of a large aggregate or
complex as AlgU was detected in inner membranes
fractions further purified by isopycnic centrifugation in
sucrose gradients from both wild-type and mucADG440
cells (IM in Fig. 4). Nevertheless, some redistribution of
AlgU from the membrane to the cytosolic fraction was
observed in mucADG440 cells (33 ^ 1% to 46 ^ 4% in the
cytoplasm for PAO1 and PAO578I respectively; P  0.02,
ANOVA). The overall level of AlgU was 1.6-fold higher
(P  0.004, ANOVA) in mucADG440 cells relative to the
mucA1 strain (Fig. 4). The increase in the overall levels of
AlgU can be attributed to increased transcription of algU from
its autoregulatory, AlgU-dependent promoters (Schurr et al.,
1995). The AlgU redistribution results are consistent with
the interpretation that MucA sequesters a portion of AlgU
to the membrane, but also suggest that appreciable
association of AlgU with the membrane occurs even when
the C-terminal domain of MucA is truncated. Because the
levels of truncated MucA are reduced in mucADG440
cells to less than 15% of the wild-type levels (Fig. 4), it is
likely that AlgU association with the membrane takes
place even in the absence of MucA. Nevertheless, the
mucADG440 mutation did cause a redistribution of AlgU
from membranes to the cytosol in addition to increasing
the absolute amounts of AlgU in the cell.
Localization of AlgU and levels of MucA in cells exposed
to environmental stress
Because adverse environmental conditions, including
elevated temperature can increase AlgU activity (Schurr
et al., 1995), we examined effects of heat shock on MucA
and AlgU levels and localization, to address the mechan-
ism of activation of the system under physiological
conditions. When wild-type mucA1 cells were exposed
to 508C for 20 min, a redistribution of AlgU to the cytosol
was observed (Fig. 5A). The fraction of AlgU in the
cytosol changed from 33 ^ 1% to 44 ^ 4% (P  0.03,
ANOVA) when compared with untreated cells. The total
levels of AlgU were increased by 1.4-fold (P  0.07,
ANOVA) relative to the untreated cells. The redistribution
of AlgU was similar to that observed in mucoid







Vector ± M 79.2 ^ 7.6
Vector 1 M 109.0 ^ 14.3
ptac±mucA1 ± M 142.6 ^ 26.4
ptac±mucA1 1 NM 4.3 ^ 0.3
ptac±mucADG440 ± M 168.9 ^ 16.0
ptac±mucADG440 1 M* 43.4 ^ 12.8
ptac±mucACF53 ± M 93.0 ^ 18.5
ptac±mucACF53 1 NM 1.3 ^ 0.2
ptac±mucACF16 ± M* 37.5 ^ 1.8
ptac±mucACF16 1 NM 1.2 ^ 0.1
ptac±mucA±FLAG ± M 260.6 ^ 6.5
ptac±mucA±FLAG 1 M 149.2 ^ 15.5
a. Plasmids were transferred into the mucADG440 strain PAO578I by
triparental conjugation.
b. Exconjugants were grown on PIA medium supplemented with
carbenicillin (300 mg ml21) and 1 mM isopropylthiogalactopyrano-
side (IPTG) where indicated.
c. M, mucoid phenotype; M*, mucoid after 48 h; NM, non-mucoid
phenotype.
d. Production of alginate is expressed in mg of uronic acid per mg
(wet weight) of cells ^ SE.
Fig. 3. Quantitation of MucA levels in mucA mutants. Levels of
protein bands immunoreactive with MucA antibody (21 kDa band for
full-size MucA in mucA1, mucACF53, and mucB::Tcr cells; 16 kDa
band in mucADG440; and 19 kDa in mucACF16) were determined by
densitometric analysis of immunoblots using three separate samples
for each strain (except mucADG440 cells where the number of
independent samples was six) and expressed relative to mucA1 cells
(set as 100%). The 16 kDa band was not detected in all samples from
mucADG440 cells and may include some intensity contributed by
cross-reacting products. Background density observed in mucA null
cells (PAO6852) was subtracted from all values. Symbols as in
Fig. 2A.
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mucADG440 strain (Fig. 4). However, the relocation of
AlgU to the cytosol in cells exposed to heat shock did not
appear caused chiefly by the degradation of MucA as the
levels of MucA increased (Fig. 5B) relative to untreated
cells (the apparent increase in MucA levels can be
attributed to elevated transcription of the algU mucABCD
gene cluster). However, an increase in MucA turnover
cannot be excluded during the process as putative
degradation intermediates of MucA became detectable,
suggestive of possible MucA degradation (Fig. 5B; lower
Mr bands).
We also examined whether a shift in temperature
can release AlgU from isolated membranes in vitro.
Membrane samples prepared from PAO1 (mucA1) and
PAO578I (mucADG440) were incubated at elevated
temperature (508C). This treatment caused an increase
in the amount of AlgU found in the supernatant after
resedimentation of the membranes in samples from
PAO1 (Fig. 5C). No similar redistribution of AlgU to
the supernatant was observed in membranes from
mucADG440 cells. These results suggest that exposure
to stress causes redistribution of AlgU if MucA is present,
and is consistent with the existence of two populations of
membrane-bound AlgU: a MucA-associated fraction and
a MucA-independent fraction, as noted in our in vivo
studies with mucA mutant cells.
Fig. 4. Localization of AlgU in wild-type and
mucADG440 cells. Immunoblot of total
extract (E), cytoplasmic (C), total membrane
(M) and inner membrane (IM) fractions
prepared from the strains PAO1 (mucA1),
PAO578I (mucADG440) and relative levels
of AlgU in each fraction relative to levels in
PAO1 (mucA1) total extract determined by
densitometric analysis. Equivalent amounts
of the protein were separated by SDS±
PAGE, electroblotted to Immobilon P
membranes, and probed with monoclonal
antibodies to AlgU. Because the bar graph in
the lower panel represents quantitation of at
least three independent sample sets some of
the values may not absolutely match the
appearance of the Western blot in the top
panel.
Fig. 5. Effect of extreme heat shock on the association of AlgU with the membrane.
A. Immunoblots probed with monclonal antibodies for AlgU of total extract (E), cytoplasmic (C), and total membrane (M) fractions prepared from
PAO1 mucA1 cells before and after exposure to 508C for 20 min. The portion of AlgU in the cytosol and membrane fractions was determined by
densitometric analysis and expressed relative to total extract levels.
B. Immunoblots of total extract of PAO1 cells prepared before or after incubation at 508C for 20 min and probed with MucA antibodies.
C. Isolated total membrane samples from PAO1 mucA1 and PAO578I (mucADG440) cells were subjected to either incubation on ice (No
treatment) or incubation at 508C for 10 min. The membranes were resedimented and equal volumes of the supernatant (S) and resuspended pellet
(P) were separated by SDS±PAGE, electroblotted to Immobilon P membranes and probed with monoclonal antibodies to AlgU. The percentage
values were calculated by dividing the intensity of bands in individual lanes by the sum of intensities of the bands in both lanes.
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Examination of the association of AlgU with the
membrane.
The observation that AlgU is able to associate with the
membrane by a mechanism independent of MucA cannot
be explained by the previous models envisioning MucA as
the tether for potential association of AlgU with the
membrane. We next considered the possibility that AlgU
could bind to the membrane via interactions with MucC,
another regulator of AlgU activity predicted to reside in the
membrane (Boucher et al., 1997a). Western blots of
cytosolic and membrane samples prepared from the
double mucA2 mucC::Gmr mutant (strain PAO6876)
revealed no change in the association of AlgU with the
membrane (data not shown), ruling out the possibility that
association with MucC could explain AlgU partitioning with
the membrane in the absence of MucA.
To examine biochemically the nature of the association
of AlgU with the membrane, samples were treated with
agents that disrupt different types of protein bonding
with membranes. These experiments were performed
on membrane samples from wild-type cells (PAO1) and
cells containing the truncation mutation mucADG440
(PAO578I). Following treatments, the membranes were
repelleted by centrifugation, and the levels of AlgU in the
supernatant (S) and in the resuspended pellet (P) were
determined by Western blots. As a control, we also
determined the levels of MucA in each fraction. Treatment
of membrane samples from wild-type strain PAO1 and the
mucADG440 strain PAO578I with 1 M NaCl or NaCl plus
25 mM EDTA which disrupt electrostatic interactions had
little or no effect on the association of AlgU or MucA with
the membrane in wild-type PAO1 cells but caused
detectable release of AlgU from membranes isolated
from PAO578 (mucADG440) (Fig. 6A). It is important to
note that recovery of total AlgU or MucA proteins varied in
some of the experiments and that the following con-
siderations are based on relative amounts between paired
S and P fractions only. Treatment of membranes with
0.15 M Na2CO3 to change the pH to 11 or under
denaturing conditions with 4 M urea caused significant
release of AlgU from the membrane (Fig. 6A). The
treatment with urea apparently affected membrane
integrity as it also caused the release of a portion of
MucA presumed to be an integral membrane protein. We
also examined the ability of AlgU to be released or
solubilized from the membrane by the zwitterionic
detergent CHAPS. The level of AlgU in the supernatant
fraction began to increase at a CHAPS concentration of
0.1% and was nearly complete with 0.5% CHAPS
(Fig. 6B and C). The release of AlgU from the membrane
began at a lower detergent concentration than expected
for an integral membrane protein as judged by the overall
change in the protein concentration in the samples or
compared with MucA release (Fig. 6B and C). In addition,
the release of AlgU was similar to the peripherally
associated inner membrane protein D-lactate dehydro-
genase (Genis and Stewart, 1996), as judged by the
changes in the distribution of the corresponding enzy-
matic activity (Fig. 6C). Based on these results, it appears
that AlgU is peripherally associated with the membrane
and is most likely bound by non-ionic interactions.
Interestingly, no major difference in the ability to remove
AlgU from the membrane by physical±chemical treatment
were observed in preparations from mucA1 and mucA
mutant cells in keeping with the possibility that a
significant fraction of membrane associated AlgU is
bound independently of interactions with MucA. In some
of the experiments described here, the recovery of
proteins after various treatments was reduced but the
yields were similar in mucA1 and mucA mutant cells.
Colocalization of membrane-bound AlgU and RNA
polymerase a subunit
The observations presented in the previous sections are
inconsistent with a simple model of AlgU inhibition by
MucA-dependent sequestration in the membrane. Thus,
we considered a more complex role for MucA and
hypothesized that the portion of AlgU that is controlled
by MucA may be affected at the stage of translocation
from the membrane during interactions with RNA poly-
merase. To test this possibility, we examined whether
RNA polymerase was associated with the membrane in
wild-type P. aeruginosa cells. Western blot analyses of
cytoplasmic and membrane fractions with sera against the
a subunit of RNA polymerase revealed that this RNA
polymerase subunit was indeed found in the membrane
fraction of mucA1 cells and in much lower (albeit
detectable) amounts in mucADG440 cells (Fig. 7A). The
greater association of RNA polymerase specifically with
membranes from mucA1 cells was further confirmed by
examining samples containing the inner membrane
fraction purified by isopycnic centrifugation in sucrose
density gradients (Fig. 7B). RNA polymerase is most
likely not associated with the MucA-independent fraction
of membrane-bound AlgU as there were no differences in
the amounts of a subunit in the inner-membrane
preparation from mucA mutant and double algU mucA
mutant cells (Fig. 7B, lanes U2 A± B1 and U1 ADG B1).
Exposure of wild-type cells to elevated temperatures also
caused a decrease in the levels of RNA polymerase a
subunit associated with the inner membrane (Fig. 7B,
compare HS with NT). These results fit a model in which
MucA acts not by simply inhibiting the association of AlgU
with RNA polymerase, but instead affects this complex on
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the membrane with AlgU already complexed with RNA
polymerase or being in a loading position.
Physiological activation of the system independent of
MucA degradation
In experiments with RNA polymerase a subunit associa-
tion with the membranes, we noticed that its levels on
membranes from the mucB mutant were not different from
levels in mucA1 strains (Fig. 7A and B). Consistent with
this finding was the observation that AlgU did not
redistribute to the cytosol in mucB::Tcr cells as the
partitioning of 68 ^ 5% of AlgU in the membrane versus
32 ^ 5% in the cytosol fraction was comparable to
mucA1 cells (Fig. 8A). It is important to note, however,
that mucA and mucB mutant strains differ in their
phenotypic expression of mucoidy. While mucADG440
cells are constitutively mucoid, mucB mutants are non-
mucoid under conditions used in experiments described in
the previous sections and become mucoid only during
Fig. 7. Association of a subunit of RNA polymerase with membranes.
A. Immunoblots of total protein extract (E), cytoplasmic (C), total
membrane (M) fractions prepared from the strains PAO1 (mucA1),
PAO578I (mucADG440), and PAO6857 (mucB::Tcr) and probed with
antibodies to the RNA polymerase a subunit (RNAP a) from E. coli.
B. Immunoblots of purified inner membrane samples probed with
antibodies to the a subunit of RNA polymerase. U1 A1 B1, PAO1
(mucA1); U± A± B1, PAO6852 (algU::Tcr::mucA); U1
AáG B1, PAO578I (mucADG440); U1 A1 B±, PAO6857
(mucB::Tcr); U1 A1 B1 NT, and HS, samples prepared from PAO1
(mucA1) cells before and after treatment with heat shock at 508C,
20 min.
Fig. 6. Nature of AlgU association with
membranes. Total membrane samples from
PAO1 mucA1 and PAO578I mucADG440
were treated with agents which disrupt
protein interactions with membranes. After
resedimentation of the membranes, equal
volumes of the supernatant (S) and
resuspended membrane pellet (P) sample
were separated by SDS±PAGE,
electroblotted to Immobilon P membranes
and probed with monoclonal antibodies to
AlgU and affinity purified antibodies to MucA.
The distribution (expressed as percentage of
total) of AlgU or MucA in each fraction was
calculated by dividing the intensity of bands
in individual lanes by the sum of intensities of
the bands in both lanes as determined by
densitometric analysis; values are given
below each lane.
A. Membrane samples were incubated with
buffer (no treatment, NT); or buffer
containing 1.0 M NaCl; 1.0 M
NaCl 1 25 mM EDTA (NaCl 1 EDTA);
100 mM Na2CO3 (pH 11.0); or 4.0 M Urea.
B. Membranes from different strains were
extracted with a buffer containing the
indicated final concentration of the
zwittergent CHAPS.
C. Protein concentration in the pellet
(squares), fractions of total D-lactate
dehydrogenase (LDH) activity in the pellet
(open circles) or supernatant (filled circles),
and fractions of total AlgU (filled triangles)
and total MucA (filled diamonds) in
supernatants of membranes samples from
PAO1 extracted with CHAPS detergent
(shown in panel B).
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growth on special media that supply additional signals
conducive to overproduction of alginate (Boucher et al.,
1997a). When mucB::Tcr cells were grown on media
promoting mucoidy, redistribution of AlgU similar to or
exceeding that seen in mucADG440 cells was observed
in the mucB::Tcr strain (Fig. 8B). Furthermore, similar
phenomena were observed with mucACF53 cells (Fig. 8A
and B). Significantly, no reduction in MucA levels was
detected in mucB::Tcr or mucACF53 cells when mucoidy-
inducing (Fig. 8C, PIA) and non-inducing (Fig. 8C, LB)
media were compared (Fig. 8C). These results suggest
that a redistribution of AlgU to the cytosol, which appears
now to always correlate with the mucoid phenotype, can
occur via a mechanism independent of MucA degrada-
tion, possibly via a conformational change in MucA.
Although an alteration of some MucA-independent
property of the membrane under conditions that promote
mucoidy cannot be excluded, it is likely that AlgU
redistribution depends on MucA or MucB as no change
in AlgU localization was detected in wild-type, mucA1
mucB1 cells when similar conditions were tested.
Model of AlgU regulation by MucA and MucB
Based on the findings presented in this study, we propose
a model (Fig. 9) of how AlgU, MucA, MucB and RNA
polymerase cooperate at the membrane. Because this
system is highly conserved (Missiakas and Raina, 1998),
and MucA±AlgU interactions appear to correspond to
RseA±sE interactions revealed both by biochemical
means (Schurr et al., 1996; Xie et al., 1996; De Las
Penas et al., 1997; Missiakas et al., 1997) and by two-
hybrid analyses (Missiakas et al., 1997), this model may
be applicable to most if not all extreme stress response
systems in Gram-negative organisms. Variations on this
theme could also be extended to at least some ECF
sigma factors in Gram-positive organisms (Gorham et al.,
1996).
AlgU associates with the bacterial inner membrane. In
Bacillus subtilis, two sigma factors, unrelated in sequence
to AlgU, are also membrane associated as an integral part
of their regulation (Haldenwang, 1995; Ju et al., 1997;
Hofmeister, 1998; Zhang et al., 1998), suggesting that
compartmentalization and control of alternative sigma
factors by processes at the membranes is a common
method of regulation in bacteria. In the case of the
extreme stress response system controlling AlgU, its
localization to the membrane most likely provides a
sensory system positioned at the frontier of the cell,
poised to recognize and respond to potentially lethal
changes in the extracellular environment.
Our results indicate that AlgU can associate with the
inner membrane in two forms: (i) as a MucA-dependent
fraction and (ii) as a MucA-independent fraction. Only the
MucA-dependent form redistributes to the cytosol if MucA
is inactive or absent. As a substantial portion of the
membrane-bound RNA polymerase shows similar depen-
dence on MucA, it is possible that MucA prevents
membrane-to-cytosol translocation of AlgU associated
with transcriptionally competent RNA polymerase. Such
preassembled complexes could ensure rapid response to
potentially fatal damage. The second MucA-independent
fraction of membrane-bound AlgU may serve as a pool
from which transcriptionally competent complexes could
Fig. 8. Changes in AlgU localization in mucB null and mucA
missense mutants require additional signals. Total protein extract (E),
cytoplasmic (C), and membrane (M) fractions were prepared from the
strains PAO1 (mucA1), PAO6902 (mucACF53), and PAO6857
(mucB::Tcr) grown either (A) in LB culture (conditions promoting non-
mucoid phenotype) or (B) on Pseudomonas isolation agar (PIA)
(conditions promoting mucoid phenotype).
A. Immunoblots from samples grown in LB media probed with
monoclonal antibodies to AlgU, and relative levels of AlgU determined
by densitometric analysis of the immunoblots.
B. Immunoblots from samples grown on Pseudomonas isolation agar
(PIA) probed with monoclonal antibodies to AlgU, and relative levels
of AlgU determined by densitometric analysis of immunoblots.
C. Relative levels of MucA determined by densitometric analysis of
MucA immunoblots of total extracts from cells grown on LB or PIA
media. The level of MucA in each sample is expressed relative to the
levels of MucA found in samples of PAO1 mucA1 grown on LB media
As the bar graph panels represent quantitation of at least three
independent sample sets, some of the values may not absolutely
match the appearance of the Western blots in the corresponding top
panels.
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be quickly replenished. As this population of AlgU does
not spontaneously dissociate from the membrane, it is
likely that AlgU translocation to the cytosol is an active
process. Furthermore, RNA polymerase appears not to
associate with the membrane-bound AlgU free of MucA
(Fig. 7B), suggesting that the assembly of AlgU and RNA
polymerase on the membrane may be a multistage
process. We postulate the existence of an intermediate
(C; see Fig. 9) consisting of AlgU bound to other factors
(possibly including RNA polymerase) that is normally
sequestered by MucA. If MucA is absent or altered to a
less-inhibitory form, the AlgU/RNA polymerase complex
translocates to the cytosol.
The majority of mucA mutations causing constitutive
expression of the system (e.g. mucADG440) destabilize
MucA and reduce or significantly diminish its levels. Less
prominent reductions in MucA amounts are seen in cells
encoding MucAP184S (CF53) and those lacking MucB. It
appears that, in such cells, additional environmental
signals can induce further changes that promote AlgU-
dependent transcription. Such changes are likely to be
conformational, as no further reduction in MucA levels is
detected. Similar changes may also function during
conditions of extreme heat shock, as in cells exposed to
508C the MucA-dependent fraction of AlgU redistributes to
the cytosol without a concomitant reduction in MucA
levels. The inhibitory conformation of MucA may be
influenced by MucB, which interacts with the periplasmic
domain of MucA. We were able to differentiate function-
ally at least two domains on MucA that play a role in
interactions with MucB. The P184S mutation reduces
MucA±MucB interactions, suggesting that this region is
involved in or is necessary for efficient MucA binding to
MucB. In contrast, deletion of a small region of the
periplasmic domain of MucA closer to its transmembrane
region improves MucB binding, suggestive of the exis-
tence of a domain in MucA that inhibits interactions with
MucB. The positive and negative interaction domains of
MucA may constitute a physiological toggle switch that
can be translated into activation or inactivation of the
extreme stress response system.
Experimental procedures
Bacterial strains and growth conditions
The laboratory strains of P. aeruginosa used in this study are
listed in Table 3. These strains are derivatives of the
standard non-mucoid genetic strain PAO1. The CF strains
used have been previously described (Boucher et al., 1997).
P. aeruginosa was grown on Luria broth (LB) or on
Pseudomonas isolation agar (PIA, Difco) supplemented
with carbenicillin (300 mg ml21), gentamicin (150 mg ml21),
tetracycline (300 mg ml21), 10% (w/v) sucrose or IPTG
(1 mM) when required. For preparation of extracts and
membranes, cultures were grown in liquid media to an A600
of 0.6±0.8 or on agar plates for 15±18 h.
Genetic manipulations, allelic replacements and
complementation analysis
The strain PAO578I (mucADG440) has been previously
described (Fyfe and Govan, 1980; Schurr et al., 1994). For
gene replacements with mucA alleles, the mucA sequences
of CF16 and CF53 were amplified from genomic DNA by
PCR using oligonucleotide UL5 (5 0-GCCGCACGTCACG-
AGC-3 0) and UR20 (5 0-CGCCAACCGCACCATCGCTC-3 0).
The resulting PCR product was cloned into pCR2.1 (Invitro-
gen), sequenced and subcloned into the non-replicative
plasmid pCVD442 (similar to pCVD441; Donnesberg and
Kaper, 1991) as an XbaI/SacI fragment. These constructs
were further modified by insertion of a Gmr cassette (Boucher
et al., 1997) from pKI11G to generate pDR130 and pDR131
containing mucACF16 and mucACF53 respectively. The
strain PAO6852 (the 3 0 end of algU and 5 0 end of mucA
gene is deleted and disrupted by a Tcr cassette; Martin et al.,
1994) was used as the recipient for a two-step allelic
exchange procedure. First, exconjugants that had integrated
the respective plasmids were selected on PIA medium
supplemented with gentamicin. Then, Gmr colonies were
subjected to selection for a second recombination event that
Fig. 9. Model of AlgU activation in muc mutants or under stress
conditions. (i) In wild-type cells in the absence of signals, the system
is arrested as a complex of AlgU with MucA and other components.
(ii) Upon exposure to stress conditions in wild-type cells, or under
growth conditions conducive to mucoidy in mucB null mutants or
mucA mutants that interfere with MucA±MucB interactions or alter
MucA function, the inhibitory activity of MucA is reduced and
transcription initiation takes place. (iii) In mucADG440, MucA is
unstable and the system is running full throttle. It is hypothesized that
transcriptionally active complexes are recruited directly from the
postulated intermediate C (AlgU±RNA polymerase transiently
associated at the membrane). Symbols: A, MucA; B, MucB; U, AlgU;
Pol, RNA polymerase; C, postulated AlgU-RNA polymerase loading
intermediate at the membrane; horizontal lines, inner membrane;
vertical lines, periplasmic (top) and cytoplasmic (bottom) domains of
MucA; dot, P184S mutation within the C-terminal domain of MucA;
bump on the periplasmic portion of MucA, MucB-interaction inhibitory
domain; patterned arrow, reduced steady-state flow due to low levels
of truncated MucA; thin arrow, low steady-state flow; thick arrow, high
steady-state or increased flow. Free cytosolic AlgU represents spent
sigma factor or sigma factor actively engaged in transcription.
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caused the loss of the plasmid sequences on PIA medium
containing 10% sucrose. The resulting colonies that were
both Gms and Tcs were identified by replica plating. The strain
PAO578I (mucADG440) has been previously described (Fyfe
and Govan, 1980; Schurr et al., 1994). All gene replacements
were confirmed by PCR amplification and sequencing.
For complementation analyses with different mucA alleles,
the PCR-derived mucA sequences of CF16 and CF53 were
subcloned into pVDtac24 (Deretic et al., 1987) as a BstYI
fragment as previously described for the construction of
ptac±mucA (Martin et al., 1993c) to generate ptac±mucACF16
and ptac±mucACF53 respectively. The plasmid ptac±
mucADG440 was created by cloning the mucA coding regions
previously amplified from PAO578I (Martin et al., 1993) into
pBluescript SK1 (Stratagene) as a XhoI±BglII fragment and
then subcloning into ptac±mucACF16 as a XhoI±SacI
fragment thereby replacing the mucACF16 sequences. To
create the mucA-FLAG allele, the 3 0 end of mucA was
modified to code for the eight residues recognized by the anti-
FLAG monoclonal antibody (Eastman Kodak Company) by
PCR amplification with oligonucleotides UL5 and MAFLAG
(5 0-TCACTTGTCATCGTCGTCCTTGTAGTCGCGGTTTTCC-
AGGCTGGCT-3 0). The resulting PCR product was ligated into
pCR2.1 (Invitrogen) and then subcloned into pVDtac24 as a
BstYI±EcoRI fragment. Production of alginate was determined
by assaying uronic acid by the method previously described by
Knutson and Jeanes (1976) after growth on PIA medium for
48 h.
Yeast two-hybrid analysis
For the two-hybrid analysis, appropriately modified algU,
mucA and mucB genes were fused to either the GAL4 DNA-
binding domain (BD) or the GAL4 activation domain (AD) of
plasmids pAS2-1 and pACT2 (Clontech) respectively. BD±
AlgU and BD±MucB were created by subcloning the modified
algU from pETU1610 (Schurr et al., 1995) and the modified
MucB minus the leader peptide from pmucBDLP (Schurr
et al., 1996) as NdeI±BglII fragments into pAS2-1. For the
construction of AD±MucA, a NcoI site was generated at the
5 0 end of mucA by PCR amplification (the NcoI site is
underlined) using oligonucleotides DR11 (5 0-AGAT-CCATGG
CTATGAGTGCTGAA-3 0) and UR20, and the modified mucA
was cloned into pACT2 as a NcoI±BglII fragment into pACT2.
For the creation of AD±MucA±CF16, AD±MucA±CF53, AD±
MucADG440 and AD±MucA±FLAG, the respective mucA
sequences previously cloned into pCR2.1 or pBluescript SK1
(mucADG440) were subcloned into pAD±MucA as XhoI±
SacI fragments thereby replacing all but the 5 0 end of the
mucA1 sequences. After creation, the DB plasmids were
transformed into the yeast strain Y187 (MATa, ura3±52,
his3±200, ade2±101, trp1±901, leu2±3, 112, gal4D , met-,
gal80D , URA3::GAL1UAS-GAL1TATA-lacZ), and the AD plas-
mids were transformed into the yeast strain Y190 (MATa,
ura3±52, his3±200, lys2±801, ade2±101, trp1±901, leu2±3,
112, gal4D , gal80D , cyhR2, URA3::GAL1UAS-GAL1TATA-lacZ,
LYS2::GAL1UAS-HIS3TATA-HIS3) respectively (Clontech).
To determine the interaction between chimeric proteins, we
monitored the expression of both the GAL1±lacZ and
GAL1UAS±HIS3 reporter genes contained in diploid cells
created from the mating of the yeast strains Y187 and Y190
carrying either the BD plasmids or the AD plasmids
respectively. The b-galactosidase activity produced from
the GAL1±lacZ gene was measured qualitatively by cleavage
of X-gal (5-bromo-4-chloro-3-indolyl-b-galactopyranoside) in
colony-lift filter assays as described in the MATCHMAKER
Two-Hybrid System 2 handbook (Clontech) and quantitatively
by cleavage of ONPG by permeablized cells from liquid
cultures (Ausubel et al., 1989). The expression of GAL1UAS±
HIS3 reporter gene was determined by scoring growth on
media lacking histidine and containing 10 mM 3-amino-
triazole (a competitive inhibitor of His3). Diploid cells were
used because they were less affected by slow growth
phenotype found in cells carrying both the BD±AlgU and
AD±MucA plasmids that caused variable colony size and
reporter expression in haploid cells.
Preparation of total protein extracts and subcellular
fractionation
Harvested cells were resuspended in cold extract buffer
[50 mM Tris-HCl, pH 7.5; 150 mM NaCl; and Completee,
EDTA-free protease inhibitor cocktail (Boehringer Man-
nheim)] and disrupted by either sonication (for smaller
preparations from 10 to 25 ml liquid culture or cells grown
on PIA plate) or by passage through a French press (for
larger preparations from 500 ml of culture to isolated inner
membrane and concentrated total membrane samples). For
separation of soluble cytoplasmic proteins from total mem-
branes, a 0.2 ml aliquot of the cell extract was subjected to
centrifugation in a Sorvall RP100AT rotor at 100 000 g for
60 min at 48C. The supernatant which contained the soluble
cytoplasmic proteins (C) was removed, and the pellet
containing total membranes (M) was washed once with






PAO1 Prototroph Alg2wt B. Holloway
PAO578I Alg1, mucADG440 Fyfe and Govan (1980); Schurr et al. (1994)
PAO578II Alg1, mucADG440 sup2 Schurr et al. (1994)
PAO6852 Alg2, algU::Tcr::mucA Martin et al. (1994)
PAO6857 Alg1, mucB::Tcr Schurr et al. (1996)
PAO6876 Alg1, mucA2 mucC::Gmr Boucher et al. (1997a)
PAO6901 Alg2, mucACF16 This work
PAO6902 Alg1, mucACF53 This work
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extract buffer and then resuspended in the original volume in
extract buffer. The cytosolic fraction contained less than 5%
of the total enzymatic activity of succinate dehydrogenase and
D-lactate dehydrogenase (LDH) activity, two inner membrane
proteins (Genis and Stewart, 1996). For the localization
comparison, an equal volume of these samples was subjected
to electrophoresis and the levels of proteins in immunoblots
determined by densitometry. Inner membranes were purified
by isopycnic centrifugation in sucrose gradients by established
methods (Hancock and Nikaido, 1978). Protein concentrations
were determined with Bio-Rad Bradford Reagent using BSA
as a standard. Succinate dehydrogenase and D-lactate
dehydrogenase activity was assayed by established methods
(Kasahara and Anraku, 1974; Kaczorowski et al., 1978).
Treatment of isolated membranes with chemicals agents
or elevated temperature
To examine the effect of chemical and physical treatments on
the association of AlgU with the membrane, a concentrated
total membrane sample was generated by centrifugation of
3.5 ml of cell extract in a Sorvall S100-AT5 rotor at 150 000 g
for 90 min at 48C and resuspending the pellet in one-seventh
the original volume. This total cellular membrane preparation
contained < 97% of the total succinate dehydrogenase
activity. An aliquot of the concentrated total membrane
sample containing 0.2 mg protein in 0.1 ml was treated with
an equal volume of extract buffer containing the chemical or
detergent at 2% concentration. After incubation for 1 h at 48C,
the membranes were pelleted by centrifugation in a Sorvall
RP100-AT rotor at 100 000 g for 60 min. The supernatant
was removed and the pellet was washed once before
resuspension in an equal volume of extract buffer. For
treatment at elevated temperature, an aliquot of the
concentrated membrane sample containing 200 mg protein
was diluted to 0.2 ml and incubated at 508C for 10 min. After
cooling on ice, the membranes were collected by centrifu-
gation as previously described. For gel electrophoresis and
immunoblot analysis, one quarter of the sample was
precipitated as described by Wessel and Flugge (1984).
Generation of peptide-specific polyclonal antibodies
against MucA
A MucA-specific peptide, MucA-pep1 (CSTWSRYQLARSV-
MHREPTL; residues 38±56 of the N-terminal, cytoplasmic
domain of MucA) was synthesized due to its predicted
hydrophilicity and antigenic index maxima (MacVector, IBI).
The synthesis of the peptide, conjugation to a carrier protein
and immunization of two rabbits was performed by Alpha
Diagnostic International. Antibodies that specifically recog-
nize the peptide were purified from sera by affinity chromato-
graphy. For this procedure, 0.2 mg of peptide was coupled to
a 1 ml HiTrap NHS-activated column (Amersham Pharmacia
Biotech) according to the manufacturer's instructions. The
antibodies in the sera were concentrated by ammonium
sulphate precipation, loaded onto the column and eluted with
0.1 M glycine-HCl, pH 2.5 as previously described (Page
et al., 1994).
Gel electrophoresis and Western blot analysis.
For the localization comparisons, equal volumes of the
extract (E), cytosolic (C) and membrane (M) fractions were
subjected to SDS±PAGE. After SDS±PAGE, the proteins
were transferred to Immobilon-P transfer membrane (Milli-
pore Corporation) and the protein detected by immunoblot
analysis using horseradish perioxidase-labelled secondary
antibodies and Western Blot Chemiluminescence Reagent
Plus (NEN Life Science Products). AlgU was detected using
murine ascites fluid 6C6 (Schurr et al., 1996) and the a
subunit of RNA polymerase was detected with rabbit
polyclonal sera generated against the a subunit of RNA
polymerase from E. coli (M. J. Chamberlin, University of
California, Berkeley) which also cross-reacts the a subunit of
RNA polymerase from P. aeruginosa. The densitometric
analysis was performed using NIH Image software (US
National Institute of Health, http://rsb.info.nih.gov/nih-image).
Statistical analysis
Analysis of variance (ANOVA), posthoc pairwise compari-
sons with the Fisher's Protected LSD test or Student's t-test
analyses were performed with SuperANOVA (version 1.11,
Abacus Concepts).
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